B. M. Trost and Y. Zhang
the addition of cinnamyl tert-butyl carbonate (0.24 mmol) via syringe.
The resulting solution was stirred at 608C under Ar for 6 h until TLC in-
dicates complete consumption of the starting oxindole. The reaction mix-
ture was then cooled to 08C, and a solution of NaOH (0.25 mL, 1m in
MeOH) was added dropwise. The resulting solution was stirred for
30 min and the reaction was then quenched with H2O (10 mL). The mix-
ture was then extracted with EtOAc (3ꢁ10 mL), dried over sodium sul-
fate, concentrated, and purified through silica gel (15% EtOAc-pentane)
to give 9g as a clear oil (50 mg, 93% yield, 98% ee, 15:1 b/l, 7:1 d.r.).
Chiral HPLC, OD-column, flow rate 1.0 mL/min, 97:3 heptane/iPrOH, tA
(minor)=13.346 min, tB (major)=15.047 min. IR (film) n˜ =: 3210, 3081,
tifying other nucleophiles that are capable of chelation con-
trol with the molybdenum catalyst.
Experimental Section
All reactions were carried out in oven-dried flasks or pyrex test tubes
under a positive pressure of argon. Anhydrous solvents were obtained
from elution through alumina column, except for THF, which was dis-
tilled from Na-benzophenone ketyl. All reagents were purchased com-
mercially and used without further purification unless stated otherwise.
TLC was performed on precoated glass plates (Merck), flash chromatog-
raphy with silica gel 60, 230–400 mesh. Enantiomeric excesses were deter-
mined by using HPLC on Tsp Spectra series P100/UV100 apparatus with
a chiral stationary phase (see details where applies). Melting points (un-
corrected) were determined in open capillary tubes by using a Thomas-
Hoover apparatus. 1H NMR (0 ppm as internal standard) and 13C NMR
(77 ppm as internal standard) spectra were recorded by using a Varian
Mercury 400 (400 MHz for 1H NMR) and by using a Unity Inova 500
(500 MHz for 1H NMR). IR spectra (cmÀ1) were obtained by using a
Perkin–Elmer FT-IR Paragon 500 spectrometer, either using neat sample
on NaCl pad (for oils and liquids), or preparing a KBr pellet.
3061, , 3030, 2975, 2887, 1707, 1619, 1471, 1452, 1334, 1230, 1202, 1123,
1
994, 917, 753, 726, 701 cmÀ1; H NMR (500 MHz, CDCl3): d=8.50
C
7.25–7.14 (m,6H), 7.04–6.97ACTHNUGRTENUNG(m, 2H), 6.84(d, J=7.5, 1H), 6.19–6.07 (m,
1H), 5.21 (dm, J=17, 1H), 5.08 (dm, J=10, 1H), 3.73(d, J=10, 1H),
1.38 ppm (s, 3H); 13C NMR (125 MHz, CDCl3) d=182.3, 140.5, 139.3,
135.7, 132.5, 129.2, 127.8, 126.8, 124.6, 121.8, 117.9, 109.5, 57.0, 52.5,
22.2 ppm; HRMS (M+H): m/z: calcd for C18H18NO: 264.1388; found:
264.1379.
Acknowledgements
General procedure for Mo catalyzed AAA reactions with 3-aryloxindoles
We thank the National Institutes of Health (NIH-13598) for their gener-
ous support of our program. Y.Z. thanks Amgen for a graduate fellow-
ship.
1-methyl-3-phenyl-3-(1-phenylallyl)indolin-2-one (2b): To an oven-dried
test tube equipped with a magnetic stir bar was added ligand L1 (4.8 mg,
0.015 mmol) and [MoACHTUNGTRENNUNG(C7H8)(CO)3] (2.7 mg, 0.01 mmol). The test tube
was sealed with a rubber septum and THF (freshly distilled and degassed,
0.3 mL) was added via syringe. The test tube was then placed in a pre-
heated oil bath at 608C for 5 min until the solution turns deep purple.
The reaction was then allowed to cool to RT. A second oven-dried test
tube containing 0.1 mmol of the oxindole was transferred to the dry box
and to it sodium tert-butoxide (0.11 mmol, 11 mg) was added. The test
tube was sealed, taken out of the dry box, and to it was added degassed
THF (0.7 mL) at room temperature. The resulting solution was stirred
for 5 min before the solution of the active catalyst solution (0.3 mL) was
added via cannula, followed by the addition of cinnamyl tert-butyl car-
bonate (0.12 mmol) via syringe. The reaction was then stirred at 608C
under Ar for 2 h at which point TLC indicated complete consumption of
the starting oxindole. The reaction was then concentrated and column
purification (10% EtOAc-pentane) afforded the desired product as a
mixture of regio- and diastereomers. (31 mg, 92%, 16:1 b/l, 9:1 d.r., 92%
ee) Chiral HPLC, AD-column, flow rate 0.7 mL/min, 90:10 heptane/
iPrOH, tA (minor)=8.387 min, tB (major)=9.556 min. IR (film) n˜ =3058,
2926, 1708, 1610, 1493, 1470, 1373, 1349, 1255, 1131, 1089, 1025, 923, 757,
[1] For recent reviews on asymmetric allylic alkylation reactions, see:
a) B. M. Trost, Russ. J. Org. Chem. 2004, 69, 5813; b) B. M. Trost,
[2] a) B. M. Stoltz, J. T. Mohr, Chem. Asian J. 2007, 2, 1476, and refer-
Chem. Soc. 2002, 120, 15164; d) K. Tissot-Croset, D. Polet, A. Alex-
[6] For recent examples of asymmetric synthesis of natural products
containing vicinal quaternary or quaternary-tertiary stereogenic cen-
ters, see: a) L. E. Overman, D. V. Paone, B. A. Stearns, J. Am.
D. J. Boehmler, G. R. Heintzelman, A. J. Barbosa, J. Am. Chem.
Soc. 2006, 128, 10572; e) J. A. Enquist, Jr., B. M. Stoltz, Nature
2008, 453, 1228.
689 cmÀ1 1H NMR (500 MHz, CDCl3) major diastereomer: d=7.61–7.58
;
(m, 2H), 7.34–7.27 (m, 2H), 7.26–7.21 (m, 2H), 7.08–6.98 (m, 5H), 6.89–
6.87 (m, 2H), 6.69(d, J=7.5, 1H), 6.06 (ddd, J=9.5, 10, 17, 1H), 5.18
(dm, J=17, 1H), 5.08 (dd, J=1.5, 10, 1H), 4.48(d, J=9.5, 1H), 3.09 ppm
(s, 3H); 13C NMR (125 MHz, CDCl3) major diastereomer: d=177.1,
143.5, 139.0, 138.0, 135.8, 129.5, 129.3, 128.2, 128.1, 128.0, 127.3, 127.2,
126.7, 126.4, 121.7, 118.5, 107.9, 60.7, 57.2, 26.1 ppm; HRMS (EI): m/z:
calcd for C24H21NO: 339.1623; found: 339.1629.
General procedure for Mo catalyzed AAA reactions with 3-alkyloxin-
doles
3-methyl-3-(1-phenylallyl)indolin-2-one
equipped with magnetic stir bar was added Ligand L1 (4.8 mg,
0.015 mmol) and [Mo(C7H8)(CO)3] (2.7 mg, 0.01 mmol). The test tube
ACHTUNGTNER(NUNG 9g): To an oven-dried test tube
a
ACHTUNGTRENNUNG
was sealed with a rubber septum and THF (freshly distilled and degassed,
0.3 mL) was added via syringe. The test tube was then placed in a pre-
heated oil bath at 608C for 5 min until the solution turns deep purple.
The test tube was then taken out of the oil bath and let cool to RT. A
second test tube containing oxindole 8g (40 mg, 0.2 mmol) was dissolved
in 1 mL dry THF and cooled to 08C. A freshly prepared solution of
sodium tert-butoxide (4 mg, 0.02 mmol) in 0.3 mL THF was added drop-
wise. The resulting solution was warmed to RT and BSA (0.24 mmol) was
added via syringe. The resulting solution stirred for 5 min before the solu-
tion of the active catalyst solution was added via cannula, followed by
[7] For some representative biologically important targets containing
oxindole structures, see: a) N. H. Greig, X. F. Pei, T. T. Soncrant,
[9] A. D. Lebsack, J. T. Link, L. E. Overman, B. A. Steans, J. Am.
302
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2010, 16, 296 – 303